Author

F. Echegaray

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

C. D. Weiss· 2 shared L. C. Katzelnick· 2 shared R. Vassell· 2 shared R. Wang· 2 shared S. Lusvarghi· 2 shared W. Wang· 2 shared A. E. Eakin· 1 shared A. Fries· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. D. Weiss

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection

W. Wang, S. Lusvarghi, R. Subramanian, E. Nusrat, R. Wang, E. Goguet, A. Fries, F. Echegaray, R. Vassell, S. Coggins, S. Richard, D. Lindholm, K. Mende, E. Ewers, D. Larson, , C. D. Weiss

The paper compares antibody responses to different SARS-CoV-2 variants after vaccination and infection, finding that post-vaccination Omicron infection induces broader immunity than triple vaccination alone.

bioRxiv · Jul 5, 2022Microbiology

SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity

S. N. Neerukonda, R. Vassell, S. Lusvarghi, R. Wang, F. Echegaray, L. Bentley, A. E. Eakin, K. J. Erlandson, L. C. Katzelnick, C. D. Weiss, W. Wang

This study evaluates the neutralization resistance and spike protein properties of SARS-CoV-2 B.1.617 variants, finding modest resistance to sera and therapeutic antibodies, but enhanced cleavage and fusogenic activity in Delta variants.

bioRxiv · Nov 5, 2021Microbiology